<DOC>
	<DOCNO>NCT00365560</DOCNO>
	<brief_summary>The primary objective study examine efficacy safety tiotropium compare plac ebo add-on therapy severe asthmatic accord GINA step 4 classification</brief_summary>
	<brief_title>An Efficacy Safety Evaluation Tiotropium add-on Therapy Patients With Severe Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Outpatients either sex , age 18 75 year , least document 5 year history asthma , current diagnosis severe , persistent asthma ( GINA step 4 ) , smoke history &lt; 10 pack year &gt; = 1 year smoking cessation ; Patients must symptomatic Patients recent history ( i.e. , six month less ) myocardial infarction , hospitalize heart failure ( NYHA class III IV ) within past year , unstable life threaten cardiac arrhythmia cardiac arrhythmia require intervention change drug therapy within past year , malignancy patient undergone resection , radiation ther apy chemotherapy within last five year , undergone thoracotomy pulmonary resection , moderate severe renal impairment ( creatinine clearance = 50 mL/min )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>